S2 Genomics: Funding, Investors & Team (Nov 2026)
S2 Genomics is a company that is working on creating solutions for spatial sequencing technology, specifically for the processing of solid tissues for single-cell applications. Their technology allows for the automated processing of raw tissues into individual cells or nuclei, which can then be used for various genomic and cell biology studies. The company's main goal is to develop products that can efficiently prepare raw tissues for genomic analyses. S2 Genomics was established in 2016 and is based in Livermore, CA.
S2 Genomics has raised $18.2M across 2 funding rounds on record, the most recent a Series A of $16.0M announced in Jan 2024.
That round is above the $8.8M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
S2 Genomics Company Profile and Key Stats
Latest funding round on record: Jan 2024.
S2 Genomics Funding Rounds
S2 Genomics raised $2.2M in an undisclosed round announced in May 2021.
2.7 years later, a Series A of $16.0M was announced in Jan 2024.
S2 Genomics Founders and Leadership Team
Contact details for the S2 Genomics team: 1 of 2 have an email address on file.
Start 14-day free trial →S2 Genomics Funding Compared to Other Biotechnology Startups
S2 Genomics' latest round of $16.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like S2 Genomics in Biotechnology and Livermore
Companies Similar to S2 Genomics
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…
Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…
Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…
100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
S2 Genomics Funding FAQs
What does S2 Genomics do?
S2 Genomics is a company that is working on creating solutions for spatial sequencing technology, specifically for the processing of solid tissues for single-cell applications. Their technology allows for the automated processing of raw tissues into individual cells or nuclei, which can then be used for various genomic and cell biology studies. The company's main goal is to develop products that can efficiently prepare raw tissues for genomic analyses. S2 Genomics was established in 2016 and is based in Livermore, CA.
How much funding has S2 Genomics raised?
S2 Genomics has raised $18.2M across 2 rounds on record. The most recent is a Series A of $16.0M announced in Jan 2024.
When did S2 Genomics last raise funding?
S2 Genomics' most recent funding round on record is a Series A of $16.0M, announced in Jan 2024.
Who founded S2 Genomics?
FundedIQ lists Peter Wagner (Founder) at S2 Genomics.
Who is the CEO of S2 Genomics?
Stevan Jovanovich is listed as CEO at S2 Genomics.
Where is S2 Genomics headquartered?
S2 Genomics is based in Livermore, California, United States.
How many employees does S2 Genomics have?
S2 Genomics is in the 11-50 employee band.
How does S2 Genomics' funding compare to other Biotechnology startups?
S2 Genomics' latest round of $16.0M is above the $8.8M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's S2 Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for S2 Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.